A Podcast on the Use of CGM in Optimizing Type 2 Diabetes Management with Non-intensive Insulin Treatment in the Primary Care Setting

被引:1
作者
Seidu, Samuel [1 ]
机构
[1] Univ Leicester, Diabet Res Ctr, Leicester Real World Evidence Unit, Leicester, England
关键词
Continuous glucose monitoring; Type; 2; diabetes; Non-intensive therapy; Primary care; Telemedicine; TECHNOLOGY;
D O I
10.1007/s13300-023-01524-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IntroductionType 2 diabetes is a widespread health concern with significant implications for patient well-being. Poor glycaemic control can lead to long-term complications, hypoglycaemia and glycaemic variability, highlighting the importance of setting treatment goals. This podcast, "The use of CGM in optimizing type 2 diabetes management with non-intensive insulin treatment in the primary care setting", introduces non-intensive insulin treatment and continuous glucose monitoring (CGM) as crucial tools in achieving these goals.Objectives and RationaleThe advantages of CGM over blood glucose monitoring (BGM) are explored, emphasizing its real-time glucose data provision and how it empowers patients to make informed treatment decisions. Drawing on randomized controlled trials (RCTs), the compelling evidence of CGM's effectiveness in patients with type 2 diabetes on basal insulin treatment are discussed. Additionally, the real-world evidence, comparing outcomes between insulin-treated and non-insulin-treated patients are also addressed. The podcast examines the link between glycaemic control and acute complications requiring hospitalizations and how CGM contributes to a better quality of life for patients with type 2 diabetes. Empowering patients is central to this podcast, with a focus on education, engagement and strategies for integrating CGM data into treatment plans. The pivotal role of healthcare providers in supporting patients on non-intensive insulin treatment and CGM in the primary care setting is addressed. Addressing challenges and barriers in CGM adoption, including cost considerations, technology accessibility and patient concerns, is vital to its widespread use. There is also a consideration of the cost-effectiveness of CGM in type 2 diabetes management. The podcast provides insights into when to consider CGM, including intermittent use and data integration with other health technologies. It emphasizes the potential for improved patient outcomes and a reduced burden of type 2 diabetes. Practical tips for interpreting the Ambulatory Glucose Profile (AGP) report are shared, benefitting primary care healthcare professionals new to CGM.ConclusionThe podcast "The use of CGM in optimizing type 2 diabetes management with non-intensive insulin treatment in the primary care setting" highlights the transformative potential of CGM in type 2 diabetes care. It encourages patients and healthcare providers to consider CGM as an integral part of treatment plans, ultimately improving the lives of those living with type 2 diabetes.28JAp7R3q_BT3_eGo-rbWBPodcast Video (MP4 261831 KB)ConclusionThe podcast "The use of CGM in optimizing type 2 diabetes management with non-intensive insulin treatment in the primary care setting" highlights the transformative potential of CGM in type 2 diabetes care. It encourages patients and healthcare providers to consider CGM as an integral part of treatment plans, ultimately improving the lives of those living with type 2 diabetes.28JAp7R3q_BT3_eGo-rbWBPodcast Video (MP4 261831 KB)
引用
收藏
页码:301 / 309
页数:9
相关论文
共 18 条
  • [1] Cost-Effectiveness Analysis of Flash Glucose Monitoring System for People with Type 2 Diabetes Receiving Intensive Insulin Treatment
    Ajjan, Ramzi
    Bilir, S. Pinar
    Hellmund, Richard
    Souto, Diana
    [J]. DIABETES THERAPY, 2022, 13 (11-12) : 1933 - 1945
  • [2] [Anonymous], 2023, ATTD 16 SCI SESSION
  • [3] IMpact of flash glucose Monitoring in pEople with type 2 Diabetes Inadequately controlled with non-insulin Antihyperglycaemic ThErapy (IMMEDIATE): A randomized controlled trial
    Aronson, Ronnie
    Brown, Ruth E.
    Chu, Lisa
    Bajaj, Harpreet S.
    Khandwala, Hasnain
    Abitbol, Alexander
    Malakieh, Nadia
    Goldenberg, Ronald
    [J]. DIABETES OBESITY & METABOLISM, 2023, 25 (04) : 1024 - 1031
  • [4] Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
    Battelino, Tadej
    Danne, Thomas
    Bergenstal, Richard M.
    Amiel, Stephanie A.
    Beck, Roy
    Biester, Torben
    Bosi, Emanuele
    Buckingham, Bruce A.
    Cefalu, William T.
    Close, Kelly L.
    Cobelli, Claudio
    Dassau, Eyal
    DeVries, J. Hans
    Donaghue, Kim C.
    Dovc, Klemen
    Doyle, Francis J.
    Garg, Satish
    Grunberger, George
    Heller, Simon
    Heinemann, Lutz
    Hirsch, Irl B.
    Hovorka, Roman
    Jia, Weiping
    Kordonouri, Olga
    Kovatchev, Boris
    Kowalski, Aaron
    Laffel, Lori
    Levine, Brian
    Mayorov, Alexander
    Mathieu, Chantal
    Murphy, Helen R.
    Nimri, Revital
    Norgaard, Kirsten
    Parkin, Christopher G.
    Renard, Eric
    Rodbard, David
    Saboo, Banshi
    Schatz, Desmond
    Stoner, Keaton
    Urakami, Tatsuiko
    Weinzimer, Stuart A.
    Phillip, Moshe
    [J]. DIABETES CARE, 2019, 42 (08) : 1593 - 1603
  • [5] Real-world study of flash glucose monitoring among adults with type 2 diabetes within the Swedish National Diabetes Register
    Eeg-Olofsson, Katarina
    Svensson, Ann-Marie
    Franzen, Stefan
    Ismail, Hodan Ahmed
    Tornblom, Michael
    Levrat-Guillen, Fleur
    [J]. DIABETES & VASCULAR DISEASE RESEARCH, 2022, 19 (01)
  • [6] Fonda Stephanie J, 2016, J Diabetes Sci Technol, V10, P898, DOI 10.1177/1932296816628547
  • [7] Important Decrease in Hospitalizations for Acute Diabetes Events Following FreeStyle Libre System Initiation in People with Type 2 Diabetes on Basal Insulin Therapy in France
    Guerci, Bruno
    Roussel, Ronan
    Levrat-Guillen, Fleur
    Detournay, Bruno
    Vicaut, Eric
    De Pouvourville, Gerard
    Emery, Corinne
    Riveline, Jean-Pierre
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 (01) : 20 - 30
  • [8] Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-Treated Type 2 Diabetes: a Multicenter, Open-Label Randomized Controlled Trial
    Haak, Thomas
    Hanaire, Helene
    Ajjan, Ramzi
    Hermanns, Norbert
    Riveline, Jean-Pierre
    Rayman, Gerry
    [J]. DIABETES THERAPY, 2017, 8 (01) : 55 - 73
  • [9] Demonstrating the Clinical Impact of Continuous Glucose Monitoring Within an Integrated Healthcare Delivery System
    Isaacson, Brad
    Kaufusi, Stephanie
    Sorensen, Jeff
    Joy, Elizabeth
    Jones, Christopher
    Ingram, Valerie
    Mark, Nickolas
    Phillips, Mike
    Briesacher, Mark
    [J]. JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY, 2022, 16 (02): : 383 - 389
  • [10] Cost-Effectiveness of the FreeStyle Libre(R) System Versus Blood Glucose Self-Monitoring in Individuals with Type 2 Diabetes on Insulin Treatment in Sweden
    Jendle, Johan
    Eeg-Olofsson, Katarina
    Svensson, Ann-Marie
    Franzen, Stefan
    Lamotte, Mark
    Levrat-Guillen, Fleur
    [J]. DIABETES THERAPY, 2021, 12 (12) : 3137 - 3152